Resistance phenotypes and genotypes of erythromycin-resistant Streptococcus pneumoniae isolates in Beijing and Shenyang, China

Antimicrobial Agents and Chemotherapy
Zhao TiemeiLiu Youning

Abstract

Of a total of 192 Streptococcus pneumoniae isolates, 149 (77.6%) were not susceptible to erythromycin. Of these 149 isolates, 117 (79.1%) contained the erm(B) gene, 16 (10.8%) contained the mef(A) gene, and 15 (10.1%) harbored both the erm(B) and mef(A) genes.

References

Jul 1, 1991·Antimicrobial Agents and Chemotherapy·R Leclercq, P Courvalin
Dec 14, 1995·The New England Journal of Medicine·J G Bartlett, L M Mundy
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·J SutcliffeL Wondrack
Jun 13, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettT M File
Oct 19, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·V D ShortridgeR K Flamm
Dec 10, 1999·The Journal of Antimicrobial Chemotherapy·A MarcheseG C Schito
Dec 20, 2000·Antimicrobial Agents and Chemotherapy·G A SyrogiannopoulosT A Davies

❮ Previous
Next ❯

Citations

Oct 26, 2012·Interdisciplinary Perspectives on Infectious Diseases·Axel Dalhoff
Sep 25, 2012·International Journal of Antimicrobial Agents·Saber Yezli, Han Li
Aug 30, 2008·International Journal of Antimicrobial Agents·Fan YangLesley McGee
Feb 19, 2013·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ivan Fan-Ngai HungRicardo Zotomayor
Aug 22, 2020·Journal of Chemotherapy·Md Moinuddin SheamSudhangshu Kumar Biswas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Related Papers

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
A PantostiM Del Grosso
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J H SongC H Pai
© 2021 Meta ULC. All rights reserved